PeptideBase
Back to Database
evidence varies by claim

Insulin

Insulin

Metabolic & Endocrine

Insulin is indexed as peptide hormone/therapeutic in the PeptideBase article library. It is referenced in “Does Semaglutide Raise Pancreatic Cancer Risk? What the Nordic Registry Study Can—and Cannot—Rule Out”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on Insulin

Start here for the plain-English articles connected to this peptide.

metabolic10 min read

Does Semaglutide Raise Pancreatic Cancer Risk? What the Nordic Registry Study Can—and Cannot—Rule Out

A Nordic registry study found no increased pancreatic cancer signal among semaglutide initiators with type 2 diabetes, but short follow-up and conference-only reporting limit what it can rule out.

Read article

Quick Facts

Origin
Named peptide hormone/therapeutic referenced in PeptideBase coverage
Category
Metabolic & Endocrine

Research Areas

metabolic

Tags

insulinpeptide hormone/therapeuticnamed peptide